CRONOS GROUP INC. Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net
CRONOS GROUP INC. (CRON) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss · last filed 2026-02-26
- CRONOS GROUP INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2025-12-31 was $0.00.
- CRONOS GROUP INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2024-12-31 was $0.00.
- CRONOS GROUP INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2024-09-30 was $32.47M.
- CRONOS GROUP INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CRONOS GROUP INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2024 was $32.47M.
- CRONOS GROUP INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2023 was $0.00.
- CRONOS GROUP INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2022 was $0.00.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 3 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 6 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 9 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $32.47M derived: sum of 2 quarters · filed 2026-02-26 | $32.47M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $32.47M 10-Q · filed 2025-11-06 | $32.47M 10-Q · filed 2025-11-06 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |